ARCHIVES

TGen At Scottsdale Opens Clinical Trial Of OSI-906 For Adrenocortical Carcinoma

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Approves Generic Capecitabine

September 20, 2013

Community Centers Group Lines Up A Speaker

January 10, 1975

Eight Centers Picked To Host Regional Breast Cancer Summits

January 31, 1992

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

Sen. Dole Raps HEW Over Delays On Patent Requests

August 11, 1978